DSCM
FLGT icon

Divisadero Street Capital Management’s Fulgent Genetics FLGT Stock Holding History

Divisadero Street Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-141,000
Closed -$5.22M – 55
2023
Q2 		$5.22M Buy
+141,000
New +$4.91M 1.51% 22

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Divisadero Street Capital Management's FLGT Position: Q3 2024 in Review

Divisadero Street Capital Management sold out of Fulgent Genetics (FLGT) in Q3 2024, closing a stake of 505,212 shares — an estimated $9.91M sold.

Divisadero Street Capital Management first reported a position in FLGT in Q4 2021 and held it in 7 quarters. The position peaked at $25.7M in Q2 2023. 183 funds tracked by Wall St. Rank hold FLGT as of Q3 2024.

  • Divisadero Street Capital Management reported no remaining Fulgent Genetics position as of Q3 2024 after selling out during the quarter.
  • Divisadero Street Capital Management sold 505,212 Fulgent Genetics shares in Q3 2024, an estimated $9.91M.
  • Divisadero Street Capital Management first reported a position in Fulgent Genetics in Q4 2021 and held it in 7 quarters.
  • Divisadero Street Capital Management's Fulgent Genetics position peaked at $25.7M in Q2 2023.
  • 183 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2024.

Based on Divisadero Street Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.